MarketCapTrends
PACB
Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare

Pacific Biosciences of California, Inc. Long Term Debt 2009–2025

Pacific Biosciences of California, Inc. annual/quarterly long term debt history from 2010 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.

  • Pacific Biosciences of California, Inc. long term debt for the quarter ending December 31, 2022 were 896.7M, a 0.07% increase year-over-year.
  • Pacific Biosciences of California, Inc. long term debt for 2022 were 896.7M, a 0.07% increase from 2021.
  • Pacific Biosciences of California, Inc. long term debt for 2021 were 896.1M, a 5545.94% increase from 2019.
  • Pacific Biosciences of California, Inc. long term debt for 2019 were 15.9M, a 8.27% increase from 2018.
  • Pacific Biosciences of California, Inc. long term debt for 2018 were 14.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Pacific Biosciences of California, Inc. Annual Long Term Debt (Millions of US $)
2022$897
2021$896
2019$16
2018$15
2017$14
2016$16
2014$14
2013$13
2012$3
2011$3
2010$3
Pacific Biosciences of California, Inc. Quarterly Long Term Debt (Millions of US $)
2022-12-31$897
2021-12-31$896
2019-12-31$16
2018-12-31$15
2017-12-31$14
2016-12-31$16
2014-12-31$14
2013-12-31$13
2012-12-31$3
2011-12-31$3
2010-12-31$3

Pacific Biosciences of California, Inc. Long Term Debt — FAQ

Pacific Biosciences of California, Inc. (PACB) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PACB's long term debt history?

The chart and table above show Pacific Biosciences of California, Inc.'s long term debt by year and by quarter, including the growth rate.